Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

[Persistent polyarticular synovitis after treatment with alendronate].

Louise Frederiksen¹, Peter Junker, Kim T Brixen

¹Odense Universitetshospital, Endokrinologisk Afdeling M. louisefrederiksen@tdcadsl.dk

Ugeskrift for Laeger

|May 9, 2007

Summary

A woman developed joint inflammation after taking osteoporosis medication alendronate. This adverse reaction, known as synovitis, persisted for over a year, suggesting a potential link to bisphosphonate drugs.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Differential DNA methylation patterns in whole blood from ACPA-positive patients with DMARD-naïve rheumatoid arthritis at clinical disease onset.

Frontiers in immunology·2025

Same author

Revisiting Circulating Extracellular Matrix Fragments as Disease Markers in Myelofibrosis and Related Neoplasms.

Cancers·2023

Same author

Serological markers of basement membrane collagen type IV and laminin are increased in systemic lupus erythematosus but differentially expressed in patients with previous cardiovascular events.

Clinical and experimental rheumatology·2023

Same author

Plasma levels of multiple cardiovascular- and inflammation-related proteins analysed for associations with disease activity and anti-cyclic citrullinated peptide status in active early rheumatoid arthritis.

Clinical and experimental rheumatology·2023

Same author

Increased Galectin-9 Levels Correlate with Disease Activity in Patients with DMARD-Naïve Rheumatoid Arthritis and Modulate the Secretion of MCP-1 and IL-6 from Synovial Fibroblasts.

Cells·2023

Same author

T-cell immunoglobulin and mucin domain 3 is upregulated in rheumatoid arthritis, but insufficient in controlling inflammation.

American journal of clinical and experimental immunology·2022

Area of Science:

Rheumatology
Pharmacology
Bone Metabolism

Background:

Osteoporosis is a common condition in post-menopausal women.
Alendronate is a widely prescribed bisphosphonate for osteoporosis treatment.
Adverse drug reactions can impact patient adherence and treatment outcomes.

Observation:

A 62-year-old woman developed polyarticular synovitis affecting hands, feet, and knees one week after initiating weekly alendronate 70 mg.
The synovitis persisted for 14 months, with residual symptoms primarily in the hands and finger joints, despite low-dose prednisolone treatment.
Two other cases of synovitis linked to bisphosphonate therapy have been documented.

Findings:

The presented case suggests a potential adverse reaction of alendronate causing persistent polyarticular synovitis.

Related Experiment Videos

The pathophysiology linking bisphosphonates to synovitis remains unknown.

This highlights a rare but significant potential side effect of bisphosphonate therapy.

Implications:

Clinicians should be aware of the potential for bisphosphonate-induced synovitis in patients with osteoporosis.
Further research is needed to elucidate the mechanism of bisphosphonate-associated synovitis.
Early recognition and management may be crucial for patients experiencing these symptoms.